Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 1;99(7):1500–1505. doi: 10.1172/JCI119312

Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.

D L Xu 1, P Y Martin 1, M Ohara 1, J St John 1, T Pattison 1, X Meng 1, K Morris 1, J K Kim 1, R W Schrier 1
PMCID: PMC507969  PMID: 9119993

Abstract

Aquaporin-2 (AQP2) mediates vasopressin-regulated collecting duct water permeability. Chronic heart failure (CHF) is characterized by abnormal renal water retention. We hypothetized that upregulation of aquaporin-2 water channel could account for the water retention in CHF. Male rats underwent either a left coronary artery ligation, a model of CHF, or were sham operated. 31-33 d after surgery, mean arterial pressure (MAP) and cardiac output were measured in conscious animals, and the animals were killed 24 h later. Cardiac output (CO) and plasma osmolality were significantly decreased and plasma vasopressin increased in the CHF as compared to the sham-operated rats. Both mRNA and protein AQP2 were significantly increased in the kidneys of the CHF rats. The effect of oral administration of a nonpeptide V2 vasopressin receptor antagonist, OPC 31260, was therefore investigated. OPC 31260 induced a significant increase in diuresis, decrease in urinary osmolality, and rise in plasma osmolality in the OPC 31260-treated CHF rats as compared to untreated CHF rats. The mRNA and protein AQP2 were significantly diminished in both cortex and inner medulla of the treated CHF rats. In conclusion, an early upregulation of AQP2 is present in CHF rats and this upregulation is inhibited by the administration of a V2 receptor antagonist. The results indicate a major role for vasopressin in the upregulation of AQP2 water channels and water retention in experimental CHF in the rat.

Full Text

The Full Text of this article is available as a PDF (268.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  2. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  3. Coleman T. G. Cardiac output by dye dilution in the conscious rat. J Appl Physiol. 1974 Sep;37(3):452–455. doi: 10.1152/jappl.1974.37.3.452. [DOI] [PubMed] [Google Scholar]
  4. DiGiovanni S. R., Nielsen S., Christensen E. I., Knepper M. A. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8984–8988. doi: 10.1073/pnas.91.19.8984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fujita N., Ishikawa S. E., Sasaki S., Fujisawa G., Fushimi K., Marumo F., Saito T. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol. 1995 Dec;269(6 Pt 2):F926–F931. doi: 10.1152/ajprenal.1995.269.6.F926. [DOI] [PubMed] [Google Scholar]
  6. Fushimi K., Uchida S., Hara Y., Hirata Y., Marumo F., Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993 Feb 11;361(6412):549–552. doi: 10.1038/361549a0. [DOI] [PubMed] [Google Scholar]
  7. Goldsmith S. R., Francis G. S., Cowley A. W., Jr Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol. 1986 Aug 1;58(3):295–299. doi: 10.1016/0002-9149(86)90065-2. [DOI] [PubMed] [Google Scholar]
  8. Hackel D. B., Ratliff N. B., Jr A technic to estimate the quantity of infarcted myocardium post mortem. Am J Clin Pathol. 1974 Feb;61(2):242–246. doi: 10.1093/ajcp/61.2.242. [DOI] [PubMed] [Google Scholar]
  9. Hayashi M., Sasaki S., Tsuganezawa H., Monkawa T., Kitajima W., Konishi K., Fushimi K., Marumo F., Saruta T. Role of vasopressin V2 receptor in acute regulation of aquaporin-2. Kidney Blood Press Res. 1996;19(1):32–37. doi: 10.1159/000174043. [DOI] [PubMed] [Google Scholar]
  10. Ishikawa S., Saito T., Okada K., Tsutsui K., Kuzuya T. Effect of vasopressin antagonist on water excretion in inferior vena cava constriction. Kidney Int. 1986 Jul;30(1):49–55. doi: 10.1038/ki.1986.149. [DOI] [PubMed] [Google Scholar]
  11. Kim J. K., Michel J. B., Soubrier F., Durr J., Corvol P., Schrier R. W. Arginine vasopressin gene expression in chronic cardiac failure in rats. Kidney Int. 1990 Nov;38(5):818–822. doi: 10.1038/ki.1990.276. [DOI] [PubMed] [Google Scholar]
  12. Kim J. K., Summer S. N., Howard R. L., Schrier R. W. Vasopressin gene expression in rats with experimental cirrhosis. Hepatology. 1993 Jan;17(1):143–147. [PubMed] [Google Scholar]
  13. Kuwahara M., Fushimi K., Terada Y., Bai L., Marumo F., Sasaki S. cAMP-dependent phosphorylation stimulates water permeability of aquaporin-collecting duct water channel protein expressed in Xenopus oocytes. J Biol Chem. 1995 May 5;270(18):10384–10387. doi: 10.1074/jbc.270.18.10384. [DOI] [PubMed] [Google Scholar]
  14. Lee W. H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986 Feb;73(2):257–267. doi: 10.1161/01.cir.73.2.257. [DOI] [PubMed] [Google Scholar]
  15. Marples D., Christensen S., Christensen E. I., Ottosen P. D., Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995 Apr;95(4):1838–1845. doi: 10.1172/JCI117863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marples D., Frøkiaer J., Dørup J., Knepper M. A., Nielsen S. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest. 1996 Apr 15;97(8):1960–1968. doi: 10.1172/JCI118628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Naitoh M., Suzuki H., Murakami M., Matsumoto A., Arakawa K., Ichihara A., Nakamoto H., Oka K., Yamamura Y., Saruta T. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol. 1994 Dec;267(6 Pt 2):H2245–H2254. doi: 10.1152/ajpheart.1994.267.6.H2245. [DOI] [PubMed] [Google Scholar]
  18. Nielsen S., Chou C. L., Marples D., Christensen E. I., Kishore B. K., Knepper M. A. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1013–1017. doi: 10.1073/pnas.92.4.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nielsen S., DiGiovanni S. R., Christensen E. I., Knepper M. A., Harris H. W. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11663–11667. doi: 10.1073/pnas.90.24.11663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nielsen S., Knepper M. A. Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes. Am J Physiol. 1993 Aug;265(2 Pt 2):F204–F213. doi: 10.1152/ajprenal.1993.265.2.F204. [DOI] [PubMed] [Google Scholar]
  21. Okada K., Ishikawa S., Caramelo C., Tsai P., Schrier R. W. Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration. Kidney Int. 1993 Oct;44(4):755–763. doi: 10.1038/ki.1993.310. [DOI] [PubMed] [Google Scholar]
  22. Pfeffer M. A., Pfeffer J. M., Fishbein M. C., Fletcher P. J., Spadaro J., Kloner R. A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res. 1979 Apr;44(4):503–512. doi: 10.1161/01.res.44.4.503. [DOI] [PubMed] [Google Scholar]
  23. SELYE H., BAJUSZ E., GRASSO S., MENDELL P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 1960 Oct;11:398–407. doi: 10.1177/000331976001100505. [DOI] [PubMed] [Google Scholar]
  24. Sands J. M., Naruse M., Jacobs J. D., Wilcox J. N., Klein J. D. Changes in aquaporin-2 protein contribute to the urine concentrating defect in rats fed a low-protein diet. J Clin Invest. 1996 Jun 15;97(12):2807–2814. doi: 10.1172/JCI118736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schrier R. W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) N Engl J Med. 1988 Oct 20;319(16):1065–1072. doi: 10.1056/NEJM198810203191606. [DOI] [PubMed] [Google Scholar]
  26. Stevens T., Morris K., McMurtry I. F., Zamora M., Tucker A. Pulmonary and systemic vascular responsiveness to TNF-alpha in conscious rats. J Appl Physiol (1985) 1993 Apr;74(4):1905–1910. doi: 10.1152/jappl.1993.74.4.1905. [DOI] [PubMed] [Google Scholar]
  27. Szatalowicz V. L., Arnold P. E., Chaimovitz C., Bichet D., Berl T., Schrier R. W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981 Jul 30;305(5):263–266. doi: 10.1056/NEJM198107303050506. [DOI] [PubMed] [Google Scholar]
  28. Terris J., Ecelbarger C. A., Nielsen S., Knepper M. A. Long-term regulation of four renal aquaporins in rats. Am J Physiol. 1996 Aug;271(2 Pt 2):F414–F422. doi: 10.1152/ajprenal.1996.271.2.F414. [DOI] [PubMed] [Google Scholar]
  29. Uchida S., Sasaki S., Fushimi K., Marumo F. Isolation of human aquaporin-CD gene. J Biol Chem. 1994 Sep 23;269(38):23451–23455. [PubMed] [Google Scholar]
  30. Yamamoto T., Sasaki S., Fushimi K., Ishibashi K., Yaoita E., Kawasaki K., Marumo F., Kihara I. Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol. 1995 Jun;268(6 Pt 1):C1546–C1551. doi: 10.1152/ajpcell.1995.268.6.C1546. [DOI] [PubMed] [Google Scholar]
  31. Yamamura Y., Ogawa H., Yamashita H., Chihara T., Miyamoto H., Nakamura S., Onogawa T., Yamashita T., Hosokawa T., Mori T. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol. 1992 Apr;105(4):787–791. doi: 10.1111/j.1476-5381.1992.tb09058.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES